Published in J Clin Microbiol on June 01, 1997
Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol (2002) 1.56
Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol (2000) 1.15
Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review. PLoS One (2013) 0.89
Very low frequence of Pneumocystis carinii DNA detection by PCR in specimens from patients with lung damage. J Clin Microbiol (2000) 0.80
Avoiding false positives with PCR. Nature (1989) 30.66
Detection of Pneumocystis carinii with DNA amplification. Lancet (1990) 5.50
A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest (1990) 3.03
Parasitologic and serologic observations of infection with Pneumocystis in humans. J Infect Dis (1977) 2.90
Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis (1982) 2.80
Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature (1991) 2.73
Pneumocystis carinii organisms derived from rat and human hosts are genetically distinct. Mol Biochem Parasitol (1991) 2.09
A search for Pneumocystis carinii in post-mortem lungs by DNA amplification. J Pathol (1992) 1.92
Pneumocystis carinii pneumonia: a cluster of eleven cases. Ann Intern Med (1975) 1.66
Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev (1991) 1.47
Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J Infect Dis (1995) 1.47
Comparison of six different PCR methods for detection of Pneumocystis carinii. J Clin Microbiol (1995) 1.45
Latency is not an inevitable outcome of infection with Pneumocystis carinii. Infect Immun (1993) 1.38
Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J Exp Med (1992) 1.36
Diagnosis of Pneumocystis carinii pneumonia: specificity and sensitivity of polymerase chain reaction in comparison with immunofluorescence in bronchoalveolar lavage specimens. J Med Microbiol (1993) 1.29
Observations favouring Pneumocystis carinii pneumonia as a primary infection: a monoclonal antibody study on paraffin sections. J Pathol (1988) 1.28
An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann Intern Med (1982) 1.27
Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect Immun (1991) 1.25
The use of a nested polymerase chain reaction for detecting Pneumocystis carinii from lung and blood in rat and human infection. J Med Microbiol (1995) 1.19
Preliminary results of Pneumocystis carinii strain differentiation by using molecular biology. J Clin Microbiol (1994) 1.11
Comparison of DNA amplification and immunofluorescence for detecting Pneumocystis carinii in patients receiving immunosuppressive therapy. Transplantation (1992) 1.08
Correlation of morphologic diagnosis of Pneumocystis carinii with the presence of pneumocystis DNA amplified by the polymerase chain reaction. Mod Pathol (1992) 1.02
Pneumocystis carinii detected in air. J Eukaryot Microbiol (1995) 0.99
Detection of DNA sequences identical to Pneumocystis carinii in samples of ambient air. J Eukaryot Microbiol (1995) 0.98
Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection. Clin Exp Immunol (1988) 0.95
Diagnosis of Pneumocystis carinii pneumonia by bronchoalveolar lavage in AIDS patients. Comparison of Diff-Quik, fungifluor stain, direct immunofluorescence test and polymerase chain reaction. Acta Cytol (1995) 0.90
Factors in an outbreak of Pneumocystis carinii in a transplant unit. Transplant Proc (1988) 0.88
Simple and rapid two-step polymerase chain reaction for diagnosis of Pneumocystis carinii infection. J Clin Microbiol (1993) 0.88
Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen. Infect Immun (1994) 0.86
A 55 kDa antigen of Pneumocystis carinii: analysis of the cellular immune response and characterization of the gene. Mol Microbiol (1993) 0.85
Laboratory diagnosis and occurrence of Pneumocystis carinii. Scand J Infect Dis Suppl (1994) 0.83
Comparison of Pneumocystis carinii detection by toluidine blue O staining, direct immunofluorescence and DNA amplification in sputum specimens from HIV positive patients. Pathology (1994) 0.82
Detection of Pneumocystis carinii DNA by polymerase chain reaction compared to direct microscopy and immunofluorescence. J Protozool (1992) 0.80
[Detection of Pneumocystis carinii in clinical samples by the polymerase chain reaction. Comparison with the methenamine silver technique]. Enferm Infecc Microbiol Clin (1993) 0.80
[Polymerase chain reaction assay for the diagnosis of pneumocystis carinii and cytomegalovirus pneumonia]. Nihon Kyobu Shikkan Gakkai Zasshi (1994) 0.77
[Usefulness of polymerase chain reaction method in the early diagnosis of Pneumocystis carinii pneumonia]. Kansenshogaku Zasshi (1994) 0.77
Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol (1993) 9.76
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36
Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol (1993) 3.83
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother (1996) 2.92
Association of shower use with Legionnaires' disease. Possible role of amoebae. JAMA (1990) 2.87
Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis (2000) 2.64
rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol (1995) 2.49
Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes (1999) 2.48
Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun (1986) 2.42
Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2010) 2.32
Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun (1994) 2.26
Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology (2007) 2.02
Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol (1995) 1.75
Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun (1993) 1.72
The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis. Bull World Health Organ (1999) 1.56
The role of ribosomal RNAs in macrolide resistance. Mol Microbiol (1997) 1.53
Systematic serologic screening for toxoplasmosis in pregnancy. Obstet Gynecol (1993) 1.50
Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol (2000) 1.50
Reevaluation of total-lymphoid irradiation and cyclosporine therapy in the Syrian hamster-to-Lewis rat cardiac xenograft model. Transplantation (1990) 1.45
Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol (2000) 1.44
Health behavior changes after colon cancer: a comparison of findings from face-to-face and on-line focus groups. Fam Community Health (2001) 1.43
Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation (1994) 1.37
Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Eur J Immunol (2001) 1.30
Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med (1979) 1.30
The antimicrobial activity of essential oils and essential oil components towards oral bacteria. Oral Microbiol Immunol (1994) 1.27
Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis (2001) 1.26
Hepatotoxicity in patients prescribed efavirenz or nevirapine. Eur J Med Res (2008) 1.26
The smad5 mutation somitabun blocks Bmp2b signaling during early dorsoventral patterning of the zebrafish embryo. Development (1999) 1.24
Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase expression. J Cell Sci (2001) 1.23
Developmental expression of a tandemly repeated, glycine- and serine-rich spore wall protein in the microsporidian pathogen Encephalitozoon cuniculi. Infect Immun (2000) 1.23
Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii. Clin Exp Immunol (1998) 1.22
Regulation of Pseudomonas aeruginosa hemF and hemN by the dual action of the redox response regulators Anr and Dnr. Mol Microbiol (1998) 1.20
Two alleles of the gene encoding surface antigen P22 in 25 strains of Toxoplasma gondii. J Parasitol (1994) 1.20
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
Human tissue responses to metal stents. Gastrointest Endosc Clin N Am (1999) 1.16
Intracellular protozoan parasites and apoptosis: diverse strategies to modulate parasite-host interactions. Trends Parasitol (2001) 1.12
Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp Parasitol (1999) 1.12
Clinical aspects and pathogenesis of Candida infection. Trends Microbiol (1998) 1.10
Clinical differences between benign and malignant pheochromocytomas. Endocr J (2001) 1.09
Measurement of spin-transfer observables in p p-->Lambda Lambda at 1.637 GeV/c. Phys Rev Lett (2002) 1.09
Use of recombinant mitogillin for improved serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol (2001) 1.07
Bradyzoite-specific gene expression in Toxoplasma gondii requires minimal genomic elements. Mol Biochem Parasitol (1997) 1.07
Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol Res (1997) 1.06
Active secretion of S100B from astrocytes during metabolic stress. Neuroscience (2006) 1.05
Apoptosis and its modulation during infection with Toxoplasma gondii: molecular mechanisms and role in pathogenesis. Curr Top Microbiol Immunol (2005) 1.05
Biocompatibility of silver-coated polyurethane catheters and silver-coated Dacron material. Biomaterials (1994) 1.03
Genetic manipulation of virulence of Yersinia enterocolitica. Contrib Microbiol Immunol (1987) 1.03
Transcriptional profile of Toxoplasma gondii-infected human fibroblasts as revealed by gene-array hybridization. Mol Genet Genomics (2001) 1.02
Smad1 and Smad5 have distinct roles during dorsoventral patterning of the zebrafish embryo. Dev Dyn (1999) 1.01
Ribosomal drug resistance in mycobacteria. Res Microbiol (1996) 1.01
Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae. Med Microbiol Immunol (2003) 1.00
Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients. Clin Biochem (2000) 1.00
A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation (1994) 1.00
Correlation of Pneumocystis carinii PCR with clinical diagnosis in immunocompromised patients. Lancet (1996) 0.99
High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapy. J Chromatogr B Biomed Sci Appl (2001) 0.98
Human tissue responses to metal stents implanted in vivo for the palliation of malignant stenoses. Gastrointest Endosc (1996) 0.97
Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii. Mol Biochem Parasitol (1998) 0.97
Efavirenz plasma levels for the prediction of treatment failure in heavily pretreated HIV-1 infected patients. Eur J Med Res (2002) 0.97
Toxoplasma gondii virulence markers identified by random amplified polymorphic DNA polymerase chain reaction. Parasitol Res (1997) 0.96
Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis. Hepatology (1988) 0.96
[Taenia crassiceps infection in AIDS]. Dtsch Med Wochenschr (1992) 0.96
Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium. Contraception (2000) 0.96
No influence of the P-glycoprotein genotype (MDR1 C3435T) on plasma levels of lopinavir and efavirenz during antiretroviral treatment. Eur J Med Res (2003) 0.94
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm (Vienna) (2005) 0.94
Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS. J Neurol (1995) 0.94
Stage differentiation of the protozoan parasite Toxoplasma gondii. Immunobiology (1999) 0.94
Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network. Eur J Clin Microbiol Infect Dis (2005) 0.93
RNA polymerase II transcription inhibits DNA repair by photolyase in the transcribed strand of active yeast genes. Nucleic Acids Res (1997) 0.93
Follistatin and noggin are excluded from the zebrafish organizer. Dev Biol (1998) 0.93
Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects. Klin Wochenschr (1982) 0.93
Nanoapatite and organoapatite implants in bone: histology and ultrastructure of the interface. J Biomed Mater Res (1995) 0.93
Evaluation of calcium phosphates and experimental calcium phosphate bone cements using osteogenic cultures. J Biomed Mater Res (2000) 0.92
Stimulation of protein phosphatases as a mechanism of the muscarinic-receptor-mediated inhibition of cardiac L-type Ca2+ channels. Pflugers Arch (1995) 0.92
Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo. J Infect Dis (1996) 0.92
The ability of selected oral microorganisms to emit red fluorescence. Caries Res (2006) 0.92
Is stage conversion the initiating event for reactivation of Toxoplasma gondii in brain tissue of AIDS patients? J Parasitol (2000) 0.91
Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone. Metabolism (1980) 0.90
Norepinephrine clearance and pressor effect in normal and hypertensive man. Klin Wochenschr (1980) 0.90
Use of serum-specific immunoglobulins A and G for detection of Helicobacter pylori infection in patients with chronic gastritis by immunoblot analysis. J Clin Microbiol (1997) 0.90
Coexistence of heterogeneous populations of Toxoplasma gondii parasites within parasitophorous vacuoles of murine macrophages as revealed by a bradyzoite-specific monoclonal antibody. Parasitol Res (1993) 0.90
Massive osteolysis (Gorham-Stout syndrome) in the maxillofacial region: an unusual manifestation. Int J Oral Maxillofac Surg (1996) 0.89
Zinc, a structural component of adenylate kinases from gram-positive bacteria. J Bacteriol (1994) 0.89
Risk factors associated with early-onset sepsis in premature infants. Eur J Obstet Gynecol Reprod Biol (1999) 0.89
Diuretic treatment and serum lipoproteins: effects of tienilic acid and indapamide. Klin Wochenschr (1981) 0.89
Bradyzoite-specific genes. Curr Top Microbiol Immunol (1996) 0.89
Invasion by Toxoplasma gondii protects human-derived HL-60 cells from actinomycin D-induced apoptosis. Med Microbiol Immunol (1999) 0.88
In vitro investigation of titanium and hydroxyapatite dental implant surfaces using a rat bone marrow stromal cell culture system. Biomaterials (2002) 0.88
Conservative replacement of methionine by norleucine in Escherichia coli adenylate kinase. J Biol Chem (1988) 0.88
Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir. Infection (2004) 0.88
[The effect of hydrochlorothiazide/amiloride alone or in combination with alpha-methyldopa on serum lipoproteins]. Schweiz Med Wochenschr (1981) 0.87
[Campylobacteriosis of man : livestock as reservoir for Campylobacter species]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2011) 0.87
Different manifestations of Toxoplasma gondii infection in F344 and LEW rats. Med Microbiol Immunol (1999) 0.87
High incidence of toxoplasmosis during pregnancy in Nigeria. Scand J Infect Dis (1996) 0.87
Cloning and characterization of zebrafish smad2, smad3 and smad4. Gene (2000) 0.87
Triple antiviral re-therapy for chronic hepatitis C with interferon-alpha, ribavirin and amantadine in nonresponders to interferon-alpha and ribavirin. Eur J Med Res (2002) 0.87
Response to treatment of chronic hepatitis C with interferon alpha in patients infected with HIV-1 is associated with higher CD4+ cell count. Infection (1998) 0.86
Metal chelating properties of adenylate kinase from Paracoccus denitrificans. Protein Eng (1998) 0.86